Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • November 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Press Release»Remlife Global Partners With JiyaYu Lifesciences To Replace Animal Inputs In APIs Via Green Chemistry
    Press Release

    Remlife Global Partners With JiyaYu Lifesciences To Replace Animal Inputs In APIs Via Green Chemistry

    WebDeskBy WebDeskMay 9, 2025No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi [India], May 9: Remlife Global PTE LTD., a Singapore-based subsidiary of BSE-listed Remedium Lifecare Ltd. (India), is pleased to announce a forward-looking partnership with JiyaYu Lifesciences PTE Ltd., a green chemistry technology platform company. This collaboration is focused on replacing animal-origin raw materials in the manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates through proprietary fermentation and biocatalyst-based alternatives.

    As part of the partnership, JiyaYu will license out fully developed and scalable technologies to Remlife Global on an exclusive basis. These technologies are designed to replace traditional animal-derived steps with sustainable, cost-effective, and regulatorycompliant bioprocesses. Remlife Global will scale up and commercialise these technologies at one or more GMP-compliant contract manufacturing sites across India, Singapore, Malta, Ireland, Belgium, and Italy.

    JiyaYu Lifesciences has in turn partnered with a UK-based R&D technology platform specialising in the development of fermentation and biocatalystbased alternatives to animal-origin pharmaceutical inputs. Through this collaboration, JiyaYu gains access to cutting-edge innovations that it will transfer to Remlife Global as fully scalable technologies.

    Each technology will be supported by detailed process dossiers and full technology transfer documents, enabling Remlife Global to implement, validate, and scale up the processes at approved GMP manufacturing sites.

    These solutions will support Remlife Global’s vision of eliminating dependence on vulnerable and ethically complex supply chains, while capturing new commercial opportunities in global regulated markets.

    “Our collaboration with JiyaYu Lifesciences is a transformative move toward building a more ethical, resilient, and sustainable pharmaceutical supply chain.” said Adarsh Munjal.

    Financial Outlook

    Each technology platform has a minimum commercial potential of ₹50 crore per product, with EBITDA margins estimated between 20% to 25%. Assuming a scale-up of two products per year, cumulative revenue and EBITDA could grow substantially:

    • FY26: 2 products | ₹100 Cr revenue | ₹20–25 Cr EBITDA
    • FY27: 4 products | ₹200 Cr revenue | ₹40–50 Cr EBITDA

    Moving Beyond Animal-Based Inputs

    Remlife Global’s strategic direction is anchored in the belief that the future of pharmaceuticals lies in sustainable, animal-free production. Key reasons for this shift include:

    • Ethical and ESG Alignment: Modern pharmaceutical companies are under growing pressure to remove animal-based components from their supply chains.
    • Safety & Quality Control: Fermentation and biocatalyst-based systems offer superior consistency and eliminate the risk of contamination from animal-borne pathogens.
    • Supply Chain Resilience: Diseases, regulatory shifts, and geopolitical volatility all threaten the availability of animal-derived inputs.
    • Environmental Benefits: Traditional animal-derived raw materials are linked to high emissions, land use, and water consumption.
    • Industry Momentum: Leading global pharma firms are rapidly adopting bio-based and cruelty-free technologies in their development pipelines.

    About Remlife Global PTE LTD.

    Remlife Global PTE LTD. is the international innovation arm of Remedium Lifecare Ltd. (India), a BSE-listed pharmaceutical company. With a focus on R&D commercialisation and strategic collaborations, Remlife Global is driving the transition to sustainable API Contract manufacturing across multiple global jurisdictions.

    Media Contact

    Adarsh Munjal

    Remlife Global PTE LTD.

    Email: info@remlife.sg

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    PR press-release
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    WebDesk
    • Website

    Related Posts

    Tutul Consulting: The CHRO’s Real Job Goes Beyond Keeping People Happy and More Toward Shaping Enterprise Mindset

    November 20, 2026

    Hardik Gajjar-led Medvyn Builds a National Platform for India’s Doctors, Hospitals and Healthcare Talent

    November 20, 2026

    How To Create a Home That Supports Both Rest and Productivity?

    November 20, 2026

    Comments are closed.

    Recent Post
    • IBMA Organises First-Ever Indian Lead Battery Conference 2026 in Goa
    • Why Creator-Gear is a B2B Business now: agencies, schools, and production houses?
    • Parul University moves to 401-500 band in Times Higher Education (THE) Interdisciplinary Science Rankings 2027
    • Tutul Consulting: The CHRO’s Real Job Goes Beyond Keeping People Happy and More Toward Shaping Enterprise Mindset
    • Hardik Gajjar-led Medvyn Builds a National Platform for India’s Doctors, Hospitals and Healthcare Talent
    • Mahanadi Coalfields becomes the third Coal India subsidiary to go public, will it continue to offer consistent returns?
    • From Needle and Thread to Virar’s Spotlight: DhaagaDhari’s Handmade Brand Wins Hearts at Virar Flea Market
    • Meeta Kotadia brings international recognition to India, winning the 2nd Runner-Up title along with two prestigious special awards at the global beauty pageant.

    Type above and press Enter to search. Press Esc to cancel.